Health tech covers organisations that apply digital tools, software, and connected hardware to healthcare delivery, clinical administration, and patient monitoring. UK exemplars BF would write about include Babylon Health, which built AI-driven triage and consultation services; Accurx, whose messaging platform sits inside NHS GP workflows; and Huma, which develops remote patient monitoring software used in clinical trials and chronic disease management. The sector spans electronic health records, diagnostic imaging software, wearables, telehealth platforms, and the data infrastructure that connects them.
BF tracks health tech because it sits at the intersection of public procurement and private capital, a combination that creates distinct commercial dynamics for SMEs and scale-ups. Selling into the NHS requires navigating procurement frameworks, information governance standards, and clinical evidence requirements that differ substantially from selling into private enterprise. Understanding how contracts are won, renewed, or lost here reveals a great deal about operational resilience and revenue predictability.
The open questions shaping the sector include how quickly NHS integrated care systems will consolidate their supplier relationships, and whether that consolidation favours established platforms or creates openings for specialists. The regulatory pathway for AI-assisted diagnostics remains unsettled, raising questions about which clinical validation standards will become the baseline. There is also an unresolved tension between interoperability ambitions, particularly around shared patient data, and the commercial incentives that lead vendors to build closed ecosystems.